Company Overview

Update
Founded:
2000
Founders:
Roger Hajjar
Headquarters:
La Jolla, CA
IPO:
Went Public on Jan 30, 2014
Stock:
CLDN
Categories:
Biotechnology
Description:
Celladon is a biotechnology company developing molecular therapies for the treatment of heart failure.

Detailed Description

Update

Celladon Corporation, a biotechnology company, develops and manufactures molecular therapies for the treatment of heart failure. Its products include SERCA2a, an enzyme that regulates calcium cycling and contractility in heart muscle cells; and MYDICAR, an enzyme replacement therapy for heart failure. The company was founded in 2000 and is based in La Jolla, California.

Current Team (2)

Update

Funding Rounds (11) - $132.5M

Update

Board Members and Advisors (3)

Update

Investors (10)

Update

Offices/Locations (2)

Update
  • Headquarters

    11988 El Camino Real

    Suite 650

    San Diego, 92130-3579

  • Office

    2223 Avenida de la Playa

    Suite 300

    La Jolla, CA 92037

    USA

Images (1)

Update
  • 698a312a49afc42905abc6ffe911c333